Sort
48,018 grants matching “immunotherapy”
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
$435,560Benjamin Aaron Alman · Duke University · R01 · FY2018 · CA
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
$435,560Benjamin Aaron Alman · Duke University · R01 · FY2016 · CA
Tumor and Immune Programming of Tumor-AssociatedEndothelium
$435,453Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2022 · CA
Dust Mite, Cockroach and Cat Allergens: Asthma
$435,451University Of Virginia Charlottesville · R01 · FY2004 · AI
TLI/ATG CONDTIONING: KIDNEY/BLOOD STEM CELL TRANSPLANTS
$435,450Stanford University · P01 · FY2004 · HL
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$435,429Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2024 · CA
Sublingual Supramolecular Vaccines and Immunotherapies
$435,384Joel H Collier · Duke University · R01 · FY2021 · AI
Project 2. Harnessing Epigenetic Regulation of Endogenous Retroelements in Melanoma
$435,370Qin Yan · Yale University · P50 · FY2025 · CA
Project 3. Overcoming Melanoma Treatment Resistance with Cytokine Immunotherapy
$435,370Aaron Michael Ring · Yale University · P50 · FY2025 · CA
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
$435,361Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2025 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$435,349Vanderbilt University · U10 · FY2002 · CA
BIOBEHAVIORAL INTERVENTIONS FOR ORAL PAIN AND MUCOSITIS
$435,313University Of Pennsylvania · R01 · FY2000 · NR
Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer
$435,266Cloud Peter Paweletz · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Sublingual Supramolecular Vaccines and Immunotherapies
$435,245Joel H Collier · Duke University · R01 · FY2022 · AI
Activation of NK cell-mediated protective immunity for the systemic treatment of ALD
$435,204Douglas Edmund Feldman · University Of Southern California · R21 · FY2023 · AA
Mechanisms of Lymphomagenesis of Skin Resident Gamma Delta T cells
$435,192Jaehyuk Choi · Northwestern University At Chicago · R01 · FY2024 · CA
Interplay Between Cancer and Immune Cells on Targeted Therapy
$435,170Peter Poon-Hang Lee · Stanford University · R01 · FY2008 · CA
Antibody Mediated Immune Regulation
$435,132James C. Zimring · Bloodworks · P01 · FY2017 · HL
Pathology Core
$435,131Xiaowei Xu · Wistar Institute · P01 · FY2019 · CA
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$435,096Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
$435,092University Of California Davis · U10 · FY2003 · CA
Pathogenesis of EBV Infection
$435,089Frederick C. Wang · Brigham And Women'S Hospital · R01 · FY2014 · CA
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · NS
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · NS
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
$435,054Wen Jiang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · NS